Member Contact: Brett Carter
Position: Chief Executive Officer
Industry: Academic Research Organisations
Cancer Therapeutics CRC (CTx) translates Australian’s cancer research into the next generation of gentler and more effective therapies for patients. CTx builds global relationships and bridges the gap between Australian research and industry.
CTx is a partnership of leading Australian research institutes, universities and end user companies.
CTx has a diverse pipeline of novel cancer drug candidates, and has secured two of the largest preclinical deals in Australia. CTx has secured three collaborative research deals with international pharmaceutical companies, delivered over $40 million in pharmaceutical revenue to the Australian economy and has six licensed preclinical candidates.